GTHX - G1 Therapeutics, Inc.

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 4.49

Open

$ 4.62

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 4.49 - $ 4.65

52 Week Range

$ 1.08 - $ 5.00

Volume

574,426

Average Volume

Market Cap

234.25M

Beta (5Y Monthly)

$ 1.57

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-01-2024	03-31-2024	10-Q
2	02-28-2024	12-31-2023	10-K
3	11-01-2023	09-30-2023	10-Q
4	08-02-2023	06-30-2023	10-Q
5	05-03-2023	03-31-2023	10-Q
6	03-01-2023	12-31-2022	10-K
7	11-02-2022	09-30-2022	10-Q
8	08-03-2022	06-30-2022	10-Q
9	05-04-2022	03-31-2022	10-Q
10	02-23-2022	12-31-2021	10-K
11	11-03-2021	09-30-2021	10-Q
12	08-04-2021	06-30-2021	10-Q
13	05-05-2021	03-31-2021	10-Q
14	02-24-2021	12-31-2020	10-K
15	11-04-2020	09-30-2020	10-Q
16	08-05-2020	06-30-2020	10-Q
17	05-06-2020	03-31-2020	10-Q
18	02-26-2020	12-31-2019	10-K
19	11-05-2019	09-30-2019	10-Q
20	08-07-2019	06-30-2019	10-Q
21	05-09-2019	03-31-2019	10-Q
22	02-28-2019	12-31-2018	10-K
23	11-07-2018	09-30-2018	10-Q
24	08-08-2018	06-30-2018	10-Q
25	05-03-2018	03-31-2018	10-Q
26	02-21-2018	12-31-2017	10-K
27	11-08-2017	09-30-2017	10-Q
28	08-09-2017	06-30-2017	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on G1 T...
05/02/2024 17:37:50

HC Wainwright & Co. analyst Edward White reiterates G1 Therapeutics (NASDAQ:GTHX) with a Buy and maintains $9 price target.

Evaluating G1 Therapeutics: Insights From ...
05/01/2024 18:00:58

Needham Reiterates Buy on G1 Therapeutics,...
05/01/2024 16:05:40

Needham analyst Gil Blum reiterates G1 Therapeutics (NASDAQ:GTHX) with a Buy and maintains $12 price target.

G1 Therapeutics Reaffirms 2024 Net COSELA ...
05/01/2024 10:33:57

G1's product revenue guidance is based on expectations for continued acceleration of sales performance of COSELA in the U.S.

G1 Therapeutics Q1 2024 GAAP EPS $(0.20), ...
05/01/2024 10:31:59

G1 Therapeutics (NASDAQ:GTHX) reported quarterly losses of $(0.20) per share which met the analyst consensus estimate. This is ...

G1 Therapeutics And Pepper Bio Announced A...
05/01/2024 10:26:52

Breaking Down G1 Therapeutics: 5 Analysts ...
04/12/2024 14:02:12

Needham Reiterates Buy on G1 Therapeutics,...
04/12/2024 10:00:06

Needham analyst Gil Blum reiterates G1 Therapeutics (NASDAQ:GTHX) with a Buy and maintains $12 price target.

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
04/08/2024 12:09:45

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
02/28/2024 17:31:10

Forecasting The Future: 5 Analyst Projecti...
02/28/2024 17:01:01

Needham Reiterates Buy on G1 Therapeutics,...
02/28/2024 16:45:12

Needham analyst Gil Blum reiterates G1 Therapeutics (NASDAQ:GTHX) with a Buy and maintains $12 price target.

G1 Therapeutics Ended 2023 With Cash, Cash...
02/28/2024 11:39:02

G1 Therapeutics Q4 EPS $(0.21) Beats $(0.2...
02/28/2024 11:38:09

G1 Therapeutics (NASDAQ:GTHX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.2...

Earnings Scheduled For February 28, 2024
02/28/2024 11:24:02

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

why-is-breast-cancer-focused-g1-therapeutics-stock-trading-lower-today

Why Is Breast Cancer-Focused G1 Therapeuti...
02/13/2024 18:24:45

Follow G1 Therapeutics as it advances trilaciclib in Phase 3 PRESERVE 2 trial for metastatic triple-negative breast cancer. Upd...

why-ipg-photonics-shares-are-trading-lower-by-around-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why IPG Photonics Shares Are Trading Lower...
02/13/2024 18:13:36

Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed four...

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
02/13/2024 17:31:12

why-zoominfo-technologies-shares-are-trading-higher-by-around-25-here-are-20-stocks-moving-premarket

Why ZoomInfo Technologies Shares Are Tradi...
02/13/2024 13:36:44

Shares of ZoomInfo Technologies Inc. (NASDAQ: ZI) rose sharply in today’s pre-market trading as the company reported stronger-...

Wedbush Maintains Outperform on G1 Therape...
02/13/2024 13:27:11

Wedbush analyst David Nierengarten maintains G1 Therapeutics (NASDAQ:GTHX) with a Outperform and lowers the price target fro...